SCHEMBL8950266

SCHEMBL8950266

COc1cccc(N2C(CO)=Cc3ccsc3S2(=O)=O)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.46
CA4 P22748 1/20 0.46
GAA P10253 2/20 0.36
SLC6A2 P23975 3/20 0.36
SLC6A3 Q01959 2/20 0.36
USP2 O75604 1/20 0.36
GFER P55789 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MGLL Q99685 1/20 0.35
LMNA P02545 1/20 0.35
ALDH1A1 P00352 2/20 0.35
NPC1 O15118 1/20 0.34
HPGD P15428 1/20 0.34
ALOX15 P16050 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8950606 0.88 CA2 (0.36) CA2CA4GAAGFERL3MBTL1
SCHEMBL8950417 0.79 ALDH1A1 (0.44) CA2CA4SMN1; SMN2LMNAALDH1A1
SCHEMBL8950506 0.70 GAA (0.31) CA2CA4GAAL3MBTL1ALDH1A1
SCHEMBL31229852 0.60 MGLL (0.50) CYP1A2MGLLLMNAALDH1A1HPGD
SCHEMBL14088564 0.59 SLC6A2 (0.65) SLC6A2SLC6A3
1,3-Dimethoxybenzene SCHEMBL27952551 0.58 MAPK1 (0.58) CA2CYP3A4LMNAALDH1A1NPC1
SCHEMBL18814554 0.58 KMT2A (0.60) CA2CA4GAACYP1A2MGLL
SCHEMBL719924 0.57 HSD17B10 (0.54) CYP1A2SMN1; SMN2MGLLLMNAALDH1A1
SCHEMBL23749751 0.57 ALDH1A1 (0.44) GFERCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL96382 0.57 TAAR1 (0.60) CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5538966-A ENZYME INHIBITORS FOR TREATMENT OF GLAUCOMA ALCON LABORATORIES, INC. (US) 1996-07-23 US disclosed